封面
市场调查报告书
商品编码
1755333

鼻整形植入物市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Rhinoplasty Implants Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年,全球鼻整形植入物市场规模达13亿美元,预计2034年将以5.9%的复合年增长率成长至26亿美元。推动这一增长的因素包括:对非侵入性鼻整形的需求激增、人们对美容手术的认知度不断提高,以及手术过程中所用材料的进步等,这些因素预计将在整个预测期内推动该行业的增长。手术技术和植入物材料的改进显着降低了併发症的风险。外科医生现在可以获得更自然的手术效果,从而提高了鼻整形手术的整体应用率。此外,更好的术后护理可以最大限度地缩短恢復时间。

鼻整形植入物市场 - IMG1

透过 3D 列印为个别患者创建量身定制的植入物,可以提高手术精确度并实现个人化治疗效果。随着硅胶等材料的不断改进,植入物不仅更安全、更耐用,更容易与人体自然组织结合。此外,封闭式鼻整形术和其他微创技术可缩短恢復时间并减少疤痕,这对患者有利。此外,由于人们意识的增强、整容手术的普及等多种因素,鼻整形手术的数量不断增加,推动了产品需求。鼻整形术是全球最常见的美容手术之一。鼻整形植入物用于重塑、增强或重建鼻部的突出度。它们由硅胶等材料製成,有助于改善鼻部的外观和功能。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 13亿美元
预测值 26亿美元
复合年增长率 5.9%

非手术隆鼻市场预计将以6%的复合年增长率成长,到2034年达到18亿美元。非手术隆鼻业务的兴起主要受欧美美容整形趋势以及社交媒体影响力不断提升等关键因素驱动。此手术使用填充剂(主要为透明质酸)来重塑鼻型,无需开刀。非手术隆鼻以其众多优势,例如微创、操作简便以及恢復期短,成为最受欢迎的美容疗程之一。此外,疫情过后,大量希望接受此类手术的年轻人选择居家办公,使得恢復过程更加便利。

2024年,医院占据市场主导地位,占45.7%,预计到2034年将达到12亿美元。由于病患安全、先进的基础设施以及经验丰富的外科专家,医院对鼻整形手术的需求一直保持强劲。医院,尤其是设有专门整形外科的医院,仍然是进行鼻整形手术的首选,因为医院能够提供患者康復所需的完整术前和术后护理。此外,医院配备了先进的监测设备和关键的救生设备,使其能够应对手术中可能出现的任何併发症。

2024年,美国鼻整形植入物市场规模达3.152亿美元。由于美观、功能性和文化因素,鼻整形手术是美国最受欢迎的手术之一,尤其受到女性的青睐。美国人会选择透过手术来改善脸部结构、矫正鼻部畸形,甚至缓解鼻中隔偏曲所引起的呼吸问题。现代社群媒体极大地推动了鼻整形手术的发展。其中包括Facebook等知名平台,在这些平台上,人们公开宣传和讚扬美丽。此外,一些有影响力的人士和公众人物对整容手术的接受度在一定程度上打破了人们对此类手术的禁忌,促使更多人考虑接受手术。此外,技术创新也进一步将此需求转化为现实。

全球鼻整形植入物产业的主要参与者包括:史赛克 (Stryker)、高德美 (Galderma)、汉森医疗 (HANSON MEDICAL)、科肯 (Koken)、戈尔 (GORE)、比斯托 (BISTOOL)、Implantech、万和 (Wanhe)、库尔兹 (Kurz)、Acteon Medical 和 Surgiform。鼻整形植入物市场的公司正在大力投资研发,以改善植入物材料和设计,从而提高安全性和患者治疗效果,从而巩固其市场地位。他们专注于利用 3D 列印技术开发个人化植入物,提供客製化解决方案,从而提高手术精度。与领先的医疗保健提供者和整形外科医生的策略合作有助于提高其产品的采用率和信任度。

目录

第一章:方法论与范围

第二章:执行摘要

第三章:行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 美容意识日益增强
      • 美容手术的技术进步
      • 非侵入性鼻整形手术的需求不断增长
    • 产业陷阱与挑战
      • 缺乏熟练的专业人员
      • 鼻整形手术费用高且併发症多
  • 成长潜力分析
  • 监管格局
  • 技术进步
  • 报销场景
  • 差距分析
  • 波特的分析
  • PESTEL分析
  • 价值链分析
  • 专利分析

第四章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章:市场估计与预测:按程序类型,2021 - 2034 年

  • 主要趋势
  • 外科
    • 开放式鼻整形术
    • 闭式鼻整形术
  • 非手术

第六章:市场估计与预测:按治疗类型,2021 - 2034 年

  • 主要趋势
  • 初次鼻整形术
  • 修復鼻整形术
  • 美容鼻整形术
  • 功能性鼻整形术
  • 其他治疗类型

第七章:市场估计与预测:按材料,2021 - 2034 年

  • 主要趋势
  • 硅胶植入物
  • Gore-Tex(ePTFE)植入物
  • 羟基磷灰石植入物
  • 其他材料

第八章:市场估计与预测:按性别,2021 - 2034 年

  • 主要趋势
  • 男性
  • 女性

第九章:市场估计与预测:依最终用途,2021 - 2034 年

  • 主要趋势
  • 医院
  • 门诊手术中心(ASC)
  • 其他最终用途

第十章:市场估计与预测:按地区,2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:公司简介

  • acteon medical
  • BISTOOL
  • Galderma
  • GORE
  • HANSON MEDICAL
  • Implantech
  • Koken
  • Kurz
  • Stryker
  • Surgiform
  • Wanhe
简介目录
Product Code: 5064

The Global Rhinoplasty Implants Market was valued at USD 1.3 billion in 2024 and is estimated to grow at a CAGR of 5.9% to reach USD 2.6 billion in 2034. The growth is driven by the surging demand for non-invasive rhinoplasty, growing awareness levels about aesthetic procedures, and advancements in materials used during the procedure among others are anticipated to fuel the industry growth throughout the forecast period. The improvement of techniques used in surgeries and the materials used for the implants has lowered the risks of complications significantly. Surgeons can now achieve more natural results, thus increasing the overall adoption of rhinoplasty procedures. In addition, better postoperative care minimizes the recovery time.

Rhinoplasty Implants Market - IMG1

The ability to create tailor-made implants for individual patients through 3D printing offers greater surgical precision and personalized results. Continuous improvements in materials such as silicone, etc. have made implants not only safer and more durable but also easier to integrate with the body's natural tissues. Additionally, closed rhinoplasty and other minimally invasive techniques ensure less recovery time and scarring which is favorable to patients. Further, the rise in the number of rhinoplasty procedures owing to several parameters such as growing awareness, high adoption of cosmetic surgeries, etc is propelling the product demand. Rhinoplasty was among the most performed aesthetic procedures worldwide. Rhinoplasty implants are used to reshape, enhance, or rebuild the projection of the nose. They are made from materials such as silicone and aid in improving the nose's appearance and functional issues.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1.3 Billion
Forecast Value$2.6 Billion
CAGR5.9%

The non-surgical segment is expected to grow at a CAGR of 6%, reaching USD 1.8 billion by 2034. The rise in non-surgical rhinoplasty is driven by key factors such as the growing trend of cosmetic procedures in Europe and America, and the rising influence of social media. This procedure uses fillers, mainly hyaluronic acid, to reshape a person's nose without requiring surgical incisions. Non-surgical rhinoplasty is among the most popular forms of aesthetic treatment owing to its numerous benefits such as a minimally-invasive and less complicated procedure coupled with a faster recovery period. In addition, post-pandemic large number of young individuals who want to undergo such procedures are working from home making it easy to faster recovery process.

The hospital segment dominated the market in 2024 with a share of 45.7% and is anticipated to reach USD 1.2 billion by 2034. The demand for rhinoplasties performed in hospitals has remained consistently strong owing to patient safety, the sophisticated infrastructure, and the presence of skilled surgical experts. Hospitals, especially those with dedicated units for plastic surgery, remain the first choice for performing rhinoplasties because the complete operative and postoperative care necessary for patient recovery are provided. In addition, hospitals are equipped with advanced monitoring and critical lifesaving devices, allowing them to handle any complications that may occur during the surgery.

U.S. Rhinoplasty Implants Market accounted for USD 315.2 million in 2024. Rhinoplasty is one of the most sought-after procedures in the U.S. especially among women owing to aesthetic, functional, and cultural considerations. Americans follow procedures that sharpen their facial structure, fix nasal irregularities, or even help with breathing problems due to a deviated septum. Rhinoplasty is heavily fueled by modern-day social media. This includes well-known platforms, such as Facebook, where beauty is endorsed and openly praised. Furthermore, the acceptance of cosmetic surgery by influencers and public figures has, to an extent, taken the taboo surrounding such procedures, leading more people to consider surgery. Additionally, technological innovations have further transformed this need into reality.

Key players in the Global Rhinoplasty Implants Industry include: Stryker, Galderma, HANSON MEDICAL, Koken, GORE, BISTOOL, Implantech, Wanhe, Kurz, Acteon Medical, and Surgiform. Companies in the rhinoplasty implants market are strengthening their foothold by investing heavily in research and development to enhance implant materials and design for better safety and patient outcomes. They focus on developing personalized implants using 3D printing technology to offer customized solutions that improve surgical precision. Strategic collaborations with leading healthcare providers and plastic surgeons help increase adoption and trust in their products.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing beauty consciousness
      • 3.2.1.2 Technological advancement in aesthetic procedures
      • 3.2.1.3 Rising demand for non-invasive rhinoplasty
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Lack of skilled professionals
      • 3.2.2.2 High cost and complications associated with rhinoplasty procedures
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology advancements
  • 3.6 Reimbursement scenario
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Value chain analysis
  • 3.11 Patent Analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Procedure Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Surgical
    • 5.2.1 Open rhinoplasty
    • 5.2.2 Closed rhinoplasty
  • 5.3 Non-surgical

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Primary rhinoplasty
  • 6.3 Revision rhinoplasty
  • 6.4 Cosmetic rhinoplasty
  • 6.5 Functional rhinoplasty
  • 6.6 Other treatment types

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Silicone implants
  • 7.3 Gore-Tex (ePTFE) implants
  • 7.4 Hydroxyapatite implants
  • 7.5 Other materials

Chapter 8 Market Estimates and Forecast, By Gender, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Male
  • 8.3 Female

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Ambulatory surgical centers (ASCs)
  • 9.4 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 acteon medical
  • 11.2 BISTOOL
  • 11.3 Galderma
  • 11.4 GORE
  • 11.5 HANSON MEDICAL
  • 11.6 Implantech
  • 11.7 Koken
  • 11.8 Kurz
  • 11.9 Stryker
  • 11.10 Surgiform
  • 11.11 Wanhe